- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 11.7M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $395K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $17.27M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.86M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.87M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.08M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $17.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $19.78M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17.97M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.83M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.13M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$15.44M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $9.4M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $32.77M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.11 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.88M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $7.68M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$25.61M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$38.85M |
| Revenue | Q1 2025 · Mar 31, 2024 | $8K |